Sort
51,593 grants matching “hepatitis”
Project 2: Molecular Signatures of West Nile virus susceptibility
$1,149,216Ruth R Montgomery · Yale University · U19 · FY2021 · AI
DEMYELINATION DISEASE--VIRAL AND IMMUNE FUNCTION
$1,149,091University Of Southern California · P01 · FY2000 · NS
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2019 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2017 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2020 · DA
Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST)
$1,148,574Juliet Iwelunmor · Washington University · UG1 · FY2024 · HD
SILVIO O.CONTE DIGESTIVE DISEASES RESEARCH CORE CENTERS
$1,148,390James Lorenzen Boyer · Yale University · P30 · FY2008 · DK
SILVIO O.CONTE DIGESTIVE DISEASES RESEARCH CORE CENTERS
$1,148,390James Lorenzen Boyer · Yale University · P30 · FY2007 · DK
MPS Qualification Section
$1,148,044Mark E Schurdak · University Of Pittsburgh At Pittsburgh · U2C · FY2024 · TR
Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome
$1,147,757Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models
$1,147,252Ashley Brown · University Of Florida · R01 · FY2014 · AI
Synthesis of Therapeutic Agents for Treatment of Infectious Diseases
$1,146,607Walter Powell · Starks Associates, Inc. · N01 · FY2013 · AI
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care
$1,146,565Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2019 · DA
Endocannabinoids And Energy Homeostasis
$1,146,334George Kunos · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA
Molecular signatures for liver cancer diagnosis and treatment stratification
$1,145,964Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings
$1,144,825Frederick Lewis Altice · Yale University · R01 · FY2025 · DA
ZCM: A novel broad-spectrum microbicide for STIs
$1,144,510Melissa J Robbiani · Population Council · U19 · FY2006 · AI
Role of Oral vs Injectable Glucagon Suppressors
$1,144,210Rubina A Heptulla · Albert Einstein College Of Medicine · DP3 · FY2013 · DK
Integrating HCV services into HIV programs for PWID in India
$1,144,204Shruti H Mehta · Johns Hopkins University · R01 · FY2021 · AI
PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis
$1,143,959Serena Patricia Koenig · Brigham And Women'S Hospital · U01 · FY2024 · AI
USC Research Center for Liver Disease
$1,143,582Neil Kaplowitz · University Of Southern California · P30 · FY2018 · DK
Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets
$1,143,103D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UG3 · FY2019 · DK
Metabolic Studies of Mouse Models of Obesity and Diabetes
$1,142,985Oksana Gavrilova · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2024 · DK
Structure-Based Vaccine Design for Hepatits C Virus
$1,142,860Thomas R Fuerst · Univ Of Maryland, College Park · R01 · FY2018 · AI
Cornell Clinical Trials Unit
$1,142,381Roy M Gulick · Weill Medical Coll Of Cornell Univ · U01 · FY2007 · AI